Eric Small, Senior Administrative Assistant for CBI, was recognized with an Outstanding Contributor Award in the 2021 MIT Excellence Awards….Continue Reading Eric Small recognized with MIT Excellence Award
Our Principles of Biomanufacturing: Using Biotechnology to Manufacture Medicines online course has just launched. This six-week self-paced course offers scientists, chemists, researchers, program managers, and other biological medicine specialists an opportunity to build an integrated understanding of their role in biomanufacturing. ENROLL NOW!…Continue Reading Enroll in MIT xPro Course through March 3rd!
BioACCESS took part in consultations and reviewed the IAVI Welcome report, which sets out a roadmap to make lifesaving antibody treatments affordable and available, particularly to those living in low- and middle-income countries. BioACCESS will take part in a series of webinars, virtual meetings, and publications to engage key stakeholders in taking concrete actions to…Continue Reading BioACCESS contributes to the IAVI Wellcome report on expanding global access to mAb-based products.
CBI has published a summary of the key takeaways from “The Impact of SARS-CoV-2 on Biomanufacturing Operations”, the first webinar in our ‘Biotechnology in the Age of COVID-19” series co-hosted by CAACB and BioMAN. The summary presents a snapshot of information drawn from expert presentations and a pre-workshop survey of consortia members, covering topics such as…Continue Reading BioPharm International publishes CBI Article on the Impact of SARS-CoV-2 on Biomanufacturing Operations
On behalf of the NEWDIGS initiative / FoCUS Project, team members submitted comments on the recent CMS Proposed Rule supporting Value-Based Purchasing (VBP) (CMS-2482-P). With active input from an engaged set of our cross-sectoral members, we focused on the Proposed Rule as an important step forward in enabling outcomes-based contracting by addressing several Medicaid Best Price methodology challenges….Continue Reading NEWDIGS offers comment on CMS Proposed Rule supporting Value-Based Purchasing, July 20th, 2020
The MIT-IBM Watson AI Lab is funding 10 research projects aimed at addressing the health and economic consequences of the pandemic, including BioACCESS’ Overcoming manufacturing and supply hurdles to provide global access to a coronavirus vaccine. The project, led by CBI’s Anthony Sinskey and Stacy Springs, will build data-driven statistical models to evaluate tradeoffs in scaling the manufacture…Continue Reading BioACCESS Receives Funding to Contribute to IBM Watson’s Initiative: Marshalling AI in the Fight Against COVID-19
This report, made possible through the efforts of our consortium members, offers lessons learned to help prevent viruses from contaminating biopharmaceutical manufacturing processes. Read the complete publication HERE. Read the MIT News piece HERE. Story: Ann Trafton, MIT News Office| Image: Betsy Skrip, CBI …Continue Reading Nature Biotechnology publishes CAACB Article on Viral Contamination in Biologic Manufacture and Implications for Emerging Therapies
In response to the COVID-19 pandemic, the Center for Biomedical Innovation has hosted a series of collaborative webinars focused on how the biomanufacturing industry is coping with COVID-19. These informal meetings will be a place where industry experts will share their organization’s response to the unique challenges now facing biomanufacturing operations. These meetings are open to…Continue Reading Biotechnology in the Age of COVID-19 Webinar Series Launched, 4/19/2020
Donovan Guttieres, a research scientist on the BioACCESS initiative, was awarded a grant to attend the Global Meeting to Accelerate Progress on SDG Target 3.4 on Noncommunicable Diseases and Mental Health, with the aim of working towards cutting preventable deaths from NCDs by 75% in the year 2035. Click HERE to read more….Continue Reading BioACCESS Attends WHO Summit on Noncommunicable Diseases
Dr. Debra Schaumberg, Vice President, Scientific Affairs, Real-World Evidence at Evidera recently sat down with Dr. Hirsch to discuss the NEWDIGS initiative, the LEAPS project, and the hope for transformation of the healthcare ecosystem. NEWDIGS is an exciting and innovative approach to developing solutions for systemwide impediments to biomedical innovation and patient care. The noncompetitive,…Continue Reading Evidera Interviews MIT CBI’s Gigi Hirsch, MD